ALX Oncology Holdings Inc. (ALXO)

NASDAQ: ALXO · IEX Real-Time Price · USD

14.21

-0.45 (-3.07%)

At close: May 17, 2024, 4:00 PM

14.00

-0.21 (-1.48%)

After-hours: May 17, 2024, 4:03 PM EDT

ALX Oncology Holdings Market Cap

ALX Oncology Holdings has a market cap or net worth of $737.74 million as of May 17, 2024. Its market cap has increased by 187.95% in one year.

Market Cap

737.74M

Enterprise Value

590.00M

1-Year Change

187.95%

Ranking

#2693

Market Cap Chart

Since July 17, 2020, ALX Oncology Holdings's market cap has decreased from $1.04B to $737.74M, a decrease of -29.15%. That is a compound annual growth rate of -8.59%.

Market Cap History

Date	Market Cap	% Change
May 17, 2024	740.30M	-3.08%
May 16, 2024	763.80M	-2.39%
May 15, 2024	782.50M	-1.00%
May 14, 2024	790.40M	-2.82%
May 13, 2024	813.30M	-3.69%
May 10, 2024	844.50M	-4.37%
May 9, 2024	883.10M	6.01%
May 8, 2024	833.00M	-5.42%
May 7, 2024	880.70M	11.28%
May 6, 2024	791.40M	2.74%
May 3, 2024	770.30M	-7.58%
May 2, 2024	833.50M	-1.90%
May 1, 2024	849.60M	-0.47%
Apr 30, 2024	853.60M	0.53%
Apr 29, 2024	849.10M	0.41%
Apr 26, 2024	845.60M	-0.06%
Apr 25, 2024	846.10M	4.01%
Apr 24, 2024	813.50M	4.64%
Apr 23, 2024	777.40M	8.93%
Apr 22, 2024	713.70M	-8.78%
Apr 19, 2024	782.40M	-0.89%
Apr 18, 2024	789.40M	-2.11%
Apr 17, 2024	806.40M	10.97%
Apr 16, 2024	726.70M	12.41%
Apr 15, 2024	646.50M	-1.07%

View and export this data all the way back to 2020. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Humacyte	753.80M
Dianthus Therapeutics	752.08M
Phibro Animal Health	744.46M
Autolus Therapeutics	743.90M
National Research	741.39M
Stoke Therapeutics	725.51M
Cogent Biosciences	717.58M
Sage Therapeutics	704.73M

Market Cap Rankings